Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Proceedings

 

 

Blennow K, Rosengren L, Wallin A. Cerebrospinal fluid findings in vascular dementia with special reference to white matter changes. In: Pantoni L, Inzitari D, Wallin A, Eds. The Matter of White Matter. Academic Pharmaceutical Productions, Dordrecht 2000:179-188.

 

Andreasen N, Winblad B, Blennow K. Cerebrospinal fluid Ab42 in Alzheimer’s disease. Research and Practice in Alzheimer's Disease 2000;3:101-105.

 

Skoog I, Blennow K. Alzheimer’s disease. In: Investigating Neurological Disease: epidemiology for clinical neurology. Eds. Hofman A, Mayeux R. Cambridge University Press, Cambridge, UK, 2001:154-173.

 

Vanmechelen E, Van Kerschaver E, Blennow K, De Deyn PP, Galasko D, Parnetti L, Sindic CJM, Arai H, Riemenscheider M, Hampel H, Pottel H, Valgaeren A, Hulstaert F, Vanderstichele H. CSF-phospho-tau (181P) as a promising marker for discriminating Alzheimer disease from dementia with Lewy Bodies. In: Alzheimer’s disease: advances in etiology, pathogenesis and therapeutics. Eds. Iqbal K, Sisodia SS, Winblad B. John Whiley & Sons Ltd, Chichester UK. 2001:285-291.

 

Blennow K, Davidsson P, Vanmechelen E. CSF markers for early Alzheimer’s disease. In: Alzheimer’s disease: Advances in Etiology, Pathogenesis and Therapeutics. Eds. Iqbal K, Sisodia SS, Winblad B. John Whiley & Sons Ltd, Chichester UK 2001:275-283.

 

Blennow K. Cerebrospinal fluid Ab and tau as biomarkers in early Alzheimer’s disease. In: Bridges into the future. Deutsche Alzheimer Gesellschaft, Berlin. 2001:401-412.

 

Hampel H, Burger K, Zinkowski R, Teipel SJ, Konken R, Kerkman D, DeBernardis J, Kahle P, Rapoport SI, Sunderland T, Arai H, Tapiola T, Hoffman-Kiefer K, Andreasen N, Blennow K, Möller HJ, Davies P. CSF tau phosphorylated at threonine 231, total tau and neuronal thread protein in the diagnosis of Alzheimer’s disease. Eur Psychiatry 2002;17(Suppl 1):77.

 

Blennow K. Tau, phospho-tau and Ab42 in cerebrospinal fluid in Alzheimer’s disease. Eur Psychiatry 2002;17(Suppl 1):77.

 

Parnetti L, Amici S, Lanari A, Romani C, Antognelli C, Andreasen N, Minthon L, Davidsson P, Pottel H, Blennow K, Gallai V. Cerebrospinal fluid levels of biomarkers and activity of acetyl cholinesterase and butyrylcholinesterase in AD patients before and after treatment with different AChE inhibitors. Neurol Sci 2002;23:S95-S96.

 

Sjögren M, Blennow K, Wallin A. Neurochemical markers. In: Vascular cognitive impairment: preventable dementia. Eds. Bowler JV, Hachinski V. Oxford University Press, Oxford, UK. 2003:208-216.

 

Andreasen N, Blennow K. CSF-tau and CSF-Ab42 as diagnostic markers for Alzheimer’s disease in clinical practice. Research and Practice in Alzheimer's Disease 2003;7:150-153.

 

Zetterberg H, Blennow K. Marqueurs du liquide cephalo-rachidien: diagnostic precoce de la maladie d’Alzheimer. In: Neurodégénérescence et viellisement cerebral. Eds. Michel BF, Verdier JM. Solal, Marseille 2004:273-281.

 

Andreasen N, Blennow K. Mild cognitive impairment (MCI) and incipient Alzheimer disease – a role for biomarkers in CSF. Research and Practice in Alzheimer's Disease 2005;10:97-100.

 

Blennow K. CSF biomarkers in Alzheimer’s disease. In: Research advances in Alzheimer’s disease and related disorders. Eds. Iqbal K, Winblad B. Alzheimer’s Association 2004:36-45.

 

Wiltfang J, Lewczuk P, Grunblatt E, Hock C, Hampel H, Vanderstichele H, Iqbal K, Galasko D, Rossor M, Lannfelt L, Otto M, Esselmann H, Henkel A, Kornhuber J, Blennow K. The role of CSF and blood analyses in the early and differential diagnosis of dementias. In: Research advances in Alzheimer’s disease and related disorders. Eds. Iqbal K, Winblad B. Alzheimer’s Association 2004:59-82.

 

Blennow K, Sjögren M, Andreasen N. Usefulness of CSF total tau, Ab42 and phospho-tau as biomarkers for Alzheimer’s disease. In: Alzheimer’s disease and related disorders: research advances. Eds: Iqbal K, Winblad B. Ana Asian Intl. Acad. Of Aging, Bucharest, Romania, 2003:247-258.

 

Vanderstichele H, Demeyer L, De Roo K, Van Remoortere S, Mortier V, Olsson A, Vandecasteele L, Kostanjevecki V, Blennow K, Vanmechelen E. Standardized multiparameter quantification of biomarkers for Alzheimer’s disease in cerebrospinal fluid. Proceedings of the 7th International Congress of Alzheimer’s and Parkinson’s disease, Sorrento, Italy, 2005:183-189.

 

Gustafson D, Blennow K. CSF Biomarkers for Alzheimer’s Disease. In: Research advances in Alzheimer’s disease and related disorders. Vol 11. Eds. Iqbal K, Winblad B. Alzheimer’s Association 2006:1-6.

Sidansvarig: Staffan Persson|Sidan uppdaterades: 2010-06-02
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?